Achromatopsia: genetics and gene therapy

S Michalakis, M Gerhardt, G Rudolph… - Molecular diagnosis & …, 2022 - Springer
Achromatopsia (ACHM), also known as rod monochromatism or total color blindness, is an
autosomal recessively inherited retinal disorder that affects the cones of the retina, the type …

Causes and consequences of inherited cone disorders

S Roosing, AAHJ Thiadens, CB Hoyng… - Progress in retinal and …, 2014 - Elsevier
Hereditary cone disorders (CDs) are characterized by defects of the cone photoreceptors or
retinal pigment epithelium underlying the macula, and include achromatopsia (ACHM), cone …

Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy

LS Carvalho, J Xu, RA Pearson, AJ Smith… - Human molecular …, 2011 - academic.oup.com
Mutations in the CNGB3 gene account for> 50% of all known cases of achromatopsia.
Although of early onset, its stationary character and the potential for rapid assessment of …

Achromatopsia: clinical features, molecular genetics, animal models and therapeutic options

N Hirji, J Aboshiha, M Georgiou, J Bainbridge… - Ophthalmic …, 2018 - Taylor & Francis
Achromatopsia is an autosomal recessive condition, characterised by reduced visual acuity,
impaired colour vision, photophobia and nystagmus. The symptoms can be profoundly …

Comprehensive variant spectrum of the CNGA3 gene in patients affected by achromatopsia

M Solaki, B Baumann, P Reuter, S Andreasson… - Human …, 2022 - Wiley Online Library
Achromatopsia (ACHM) is a congenital cone photoreceptor disorder characterized by
impaired color discrimination, low visual acuity, photosensitivity, and nystagmus. To date, six …

[HTML][HTML] Achromatopsia

S Kohl, H Jägle, B Wissinger, D Zobor - 2018 - europepmc.org
Achromatopsia is characterized by reduced visual acuity, pendular nystagmus, increased
sensitivity to light (photophobia), a small central scotoma, eccentric fixation, and reduced or …

[HTML][HTML] The clinical phenotype of CNGA3-related achromatopsia: pretreatment characterization in preparation of a gene replacement therapy trial

D Zobor, A Werner, F Stanzial… - … & Visual Science, 2017 - tvst.arvojournals.org
Purpose: The purpose of this study was to clinically characterize patients with CNGA3-linked
achromatopsia (CNGA3-ACHM) in preparation of a gene therapy trial. Methods: Thirty-six …

Biology, pathobiology and gene therapy of CNG channel-related retinopathies

MJ Gerhardt, SG Priglinger, M Biel, S Michalakis - Biomedicines, 2023 - mdpi.com
The visual process begins with the absorption of photons by photopigments of cone and rod
photoreceptors in the retina. In this process, the signal is first amplified by a cyclic guanosine …

[HTML][HTML] Genotypes and phenotypes of genes associated with achromatopsia: A reference for clinical genetic testing

W Sun, S Li, X Xiao, P Wang, Q Zhang - Molecular vision, 2020 - ncbi.nlm.nih.gov
Purpose Achromatopsia is a congenital autosomal recessive cone disorder, and it has been
found to be associated with six genes. However, pathogenic variants in these six genes …

Structural and functional characterization of an achromatopsia-associated mutation in a phototransduction channel

X Zheng, H Li, Z Hu, D Su, J Yang - Communications Biology, 2022 - nature.com
Numerous missense mutations in cyclic nucleotide-gated (CNG) channels cause
achromatopsia and retinitis pigmentosa, but the underlying pathogenic mechanisms are …